Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001368324-26-000002

Options or other derivatives

  • Director acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Friedman Bart Director 2026-02-26 Grant or award · Employee Stock Option (Right to Buy) +65,000 65,000 D: show line 1 in the form
Loading xslF345X05/form4-03022026_040311.xml…